Related Experiment Video
Updated: Jun 10, 2026

Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
The C terminus of p53 binds the N-terminal domain of MDM2
Masha V Poyurovsky1, Chen Katz, Oleg Laptenko
1Department of Biological Sciences, Columbia University, New York, New York, USA.
Abstract:
The p53 tumor suppressor interacts with its negative regulator Mdm2 via the former's N-terminal region and core domain, yet the extreme p53 C-terminal region contains lysine residues ubiquitinated by Mdm2 and can bear post-translational modifications that inhibit Mdm2-p53 association. We show that the Mdm2-p53 interaction is decreased upon deletion, mutation or acetylation of the p53 C terminus. Mdm2 decreases the association of full-length but not C-terminally deleted p53 with a DNA target sequence in vitro and in cells. Further, using multiple approaches, we show that a peptide from the p53 C terminus directly binds the Mdm2 N terminus in vitro. We also show that p300-acetylated p53 inefficiently binds Mdm2 in vitro, and Nutlin-3 treatment induces C-terminal modification(s) of p53 in cells, explaining the low efficiency of Nutlin-3 in dissociating p53-MDM2 in vitro.
Insights
The p53 C-terminus regulates its interaction with Mdm2, a key negative regulator. Modifications to the p53 C-terminus, like acetylation, reduce Mdm2 binding, impacting tumor suppressor activity.
Area of Science:
- Molecular Biology
- Cancer Research
- Protein Interactions
Background:
- The p53 tumor suppressor protein is regulated by its interaction with Mdm2.
- Mdm2 acts as a negative regulator of p53, targeting it for degradation.
- The p53 C-terminus contains sites for Mdm2-mediated ubiquitination and other post-translational modifications.
Purpose of the Study:
- To investigate the role of the p53 C-terminus in regulating the Mdm2-p53 interaction.
- To determine how post-translational modifications of the p53 C-terminus affect Mdm2 binding.
- To elucidate the mechanism by which Mdm2 influences p53 binding to DNA.
Main Methods:
- Site-directed mutagenesis to delete or mutate the p53 C-terminus.
- In vitro binding assays using peptides and full-length proteins.
- Cell-based assays to assess Mdm2-p53 association and DNA binding.
- Analysis of p53 acetylation and other modifications.
Main Results:
- Deletion, mutation, or acetylation of the p53 C-terminus decreased the Mdm2-p53 interaction.
- Mdm2 binding to DNA was inhibited by full-length p53 but not C-terminally deleted p53.
- A p53 C-terminal peptide directly bound to the Mdm2 N-terminus.
- p300-acetylated p53 showed inefficient binding to Mdm2 in vitro.
- Nutlin-3 treatment induced p53 C-terminal modifications, explaining its limited efficacy in dissociating p53-Mdm2 complexes.
Conclusions:
- The p53 C-terminus is a critical regulatory region for the Mdm2-p53 interaction.
- Post-translational modifications of the p53 C-terminus modulate Mdm2 binding and p53 activity.
- Understanding these interactions is crucial for developing targeted cancer therapies.
Related Concept Videos
Abnormal Proliferation
Separation of Sister Chromatids
At the onset of anaphase, separase, a proteolytic enzyme, is...
Anaphase Promoting Complex
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules

